Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers

A method of treating cancer in a HLA-A*02+ patient, wherein said cancer comprises cancer cells that overexpress SLC25A3 and present at their surface in complex with an MHC class I molecule a peptide consisting of SEQ ID NO:

• 61, said method comprising administering to said patient an effective amount of activated antigen-specific CD8+ cytotoxic T cells to kill the cancer cells, wherein said activated antigen-specific CD8+ cytotoxic T cells are produced by contacting in vitro CD8+ cytotoxic T cells with an antigen presenting cell presenting at its surface in complex with an MHC class 1 molecule a peptide consisting of SEQ ID NO:
• 61, wherein said cancer is selected from head and neck cancer, non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), renal cell carcinoma (RCC), brain cancer, gastric cancer (GC), chronic lymphatic leukemia (CLL), non-Hodgkin lymphoma (NHL), esophageal cancer, gallbladder cancer, bile duct cancer, and liver cancer (HCC).